UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
First Trust Dow Jones Select MicroCap Index Fund
FDM
$261M
| $745 | ﹤0.01% |
8
| – | – |
2026 Q1
1 quarter
|
|
3602
Inogen
INGN
$164M
| $716 | ﹤0.01% |
111
| – | – |
2026 Q1
1 quarter
|
|
3603
Franklin Covey
FC
$205M
| $687 | ﹤0.01% |
28
| – | – |
2025 Q4
2 quarters
|
|
3604
Travelzoo
TZOO
$53.3M
| $642 | ﹤0.01% |
55
| – | – |
2026 Q1
1 quarter
|
|
|
OPRA
3605
Opera Ltd
OPRA
$1.56B
| $635 | ﹤0.01% |
32
| – | – |
2025 Q4
2 quarters
|
|
3606
Gray Television
GTN
$468M
| $615 | ﹤0.01% |
155
| – | – |
2026 Q1
1 quarter
|
|
|
SFD
3607
Smithfield Foods
SFD
$7.33B
| $607 | ﹤0.01% |
25
| – | – |
2026 Q1
1 quarter
|
|
3608
Microvision
MVIS
$36.7M
| $588 | ﹤0.01% |
120
| – | – |
2026 Q1
1 quarter
|
|
3609
Helen of Troy
HELE
$620M
| $581 | ﹤0.01% |
20
| – | – |
2013 Q2
52 quarters
|
|
3610
Anavex Life Sciences
AVXL
$138M
| $575 | ﹤0.01% |
222
| – | – |
2025 Q1
5 quarters
|
|
3611
Johnson Outdoors
JOUT
$448M
| $552 | ﹤0.01% |
12
| – | – |
2026 Q1
1 quarter
|
|
3612
Friedman Industries
FRD
$303M
| $547 | ﹤0.01% |
17
| – | – |
2026 Q1
1 quarter
|
|
3613
InMode
INMD
$818M
| $541 | ﹤0.01% |
37
-78,127
| -100% | -$1.09M |
2025 Q4
2 quarters
|
|
3614
Agilon Health
AGL
$1.38B
| $536 | ﹤0.01% |
5
| – | – |
2021 Q2
20 quarters
|
|
|
ITRG
3615
Integra Resources
ITRG
$534M
| $529 | ﹤0.01% |
233
| – | – |
2026 Q1
1 quarter
|
|
3616
Black Diamond Therapeutics
BDTX
$105M
| $509 | ﹤0.01% |
275
| – | – |
2026 Q1
1 quarter
|
|
3617
NACCO Industries
NC
$268M
| $501 | ﹤0.01% |
10
| – | – |
2026 Q1
1 quarter
|
|
3618
iShares MSCI France ETF
EWQ
$332M
| $500 | ﹤0.01% |
11
| – | – |
2026 Q1
1 quarter
|
|
3619
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
| $493 | ﹤0.01% |
11
-170
| -94% | -$7.83K |
2025 Q4
2 quarters
|
|
3620
Nano X Imaging
NNOX
$42.3M
| $488 | ﹤0.01% |
421
| – | – |
2026 Q1
1 quarter
|
|
3621
Stem
STEM
$40M
| $484 | ﹤0.01% |
62
| – | – |
2026 Q1
1 quarter
|
|
3622
Acme United Corp
ACU
$238M
| $477 | ﹤0.01% |
10
| – | – |
2026 Q1
1 quarter
|
|
3623
Mistras Group
MG
$662M
| $472 | ﹤0.01% |
27
| – | – |
2026 Q1
1 quarter
|
|
3624
USCB Financial Holdings
USCB
$407M
| $471 | ﹤0.01% |
23
| – | – |
2026 Q1
1 quarter
|
|
3625
SOPHiA GENETICS
SOPH
$631M
| $444 | ﹤0.01% |
77
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.